Barclays’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
Barclays's KYNB Position: Q3 2026 in Review
Barclays opened a new position in Kyntra Bio (KYNB) in Q3 2026: 3 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #5126 among its holdings. This is a return to the name: Barclays previously reported a position in KYNB as recently as Q2 2024.
Barclays first reported a position in KYNB in Q4 2014 and has held it in 39 quarters since. The position peaked at $8.1M in Q4 2019. 35 funds tracked by Wall St. Rank hold KYNB as of Q3 2026.
- Barclays held 3 shares of Kyntra Bio worth $20 as of Q3 2026.
- Kyntra Bio was a new Barclays position in Q3 2026.
- Kyntra Bio made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5126 holding.
- Barclays first reported a position in Kyntra Bio in Q4 2014 and has held it in 39 quarters since.
- Barclays's Kyntra Bio position peaked at $8.1M in Q4 2019.
- 35 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.